Tag: Michael Leiter
Skadden, Latham & Watkins steer USD1.12bn biotech sale
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
A 1,200-article code, five interlocking books, and one tighter leash on Chinese business. The clock to August 2026 is ticking
Paul Chow shares his views on shaping HKEX legal strategy, sustainability leadership and responsible AI use in markets